Utah Medical Products, Inc. logo

UTMD

Utah Medical Products, Inc.

$90.05

Earnings Summary

Revenue
$13.43Mn
Net Profits
$4.1Mn
Net Profit Margins
30.56%
PE Ratio
21.35

Highlights

Revenue:

Utah Medical Products, Inc.’s revenue jumped 6.54% since last year same period to $13.43Mn in the Q2 2022. On a quarterly growth basis, Utah Medical Products, Inc. has generated 8.97% jump in its revenue since last 3-months.

Net Profits:

Utah Medical Products, Inc.’s net profit jumped 19.76% since last year same period to $4.1Mn in the Q2 2022. On a quarterly growth basis, Utah Medical Products, Inc. has generated 16.1% jump in its net profits since last 3-months.

Net Profit Margins:

Utah Medical Products, Inc.’s net profit margin jumped 12.41% since last year same period to 30.56% in the Q2 2022. On a quarterly growth basis, Utah Medical Products, Inc. has generated 6.55% jump in its net profit margins since last 3-months.

PE Ratio:

Utah Medical Products, Inc.’s price-to-earnings ratio after this Q2 2022 earnings stands at 21.35.

Key Ratios

Key ratios of the Utah Medical Products, Inc. post its Q2 2022 earnings

Earning Per Share (EPS)
1.12
Return on Assets (ROA)
0.1
Return on Equity (ROE)
0.14
Dividend Per Share (DPS)
0.86

Highlights

Earning Per Share (EPS):

Utah Medical Products, Inc.’s earning per share (EPS) fell -2.25% since last year same period to 1.12 in the Q2 2022. This indicates that the Utah Medical Products, Inc. has generated -2.25% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Utah Medical Products, Inc.’s return on assets (ROA) stands at 0.1.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Utah Medical Products, Inc.’s return on equity (ROE) stands at 0.14.

Dividend Per Share (DPS):

Utah Medical Products, Inc. declared 0.86 dividend per share during the earnings announcement for Q2 2022.

Company Information

Utah Medical Products, Inc. with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long term outcomes for their patients.

Organisation
Utah Medical Products, Inc.
Headquarters
7043 South 300 West, Midvale, UT, United States, 84047-1048
Employees
181
Industry
Health Technology
CEO
Kevin Cornwell